4.7 Article

Alternative translation initiation of Caveolin-2 desensitizes insulin signaling through dephosphorylation of insulin receptor by PTP1B and causes insulin Check for resistance

Journal

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbadis.2018.03.022

Keywords

Caveolin-2; Alternative translation initiation; Insulin receptor; Protein tyrosine phosphatase 1B; Lysosomal degradation; Insulin resistance

Funding

  1. National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2011-0014898]
  2. Ministry of Education (ME) [NRF-2015R1D1A3A01016537, NRF-2015R1D1A4A01017437, NRF-2018R1C1B6006816, NRF-2015R1A6A3A01016424]
  3. National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [1631090]
  4. Next-Generation BioGreen 21 Program from the Rural Development Administration of Korea (SSAC) [PJ01137901]
  5. Development Fund Foundation, Gyeongsang National University
  6. Global Ph.D. Fellowship Program [NRF-2013H1A2A1034489]
  7. BK21 Plus Program
  8. Korea Health Promotion Institute [1631090] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  9. National Research Foundation of Korea [2018R1D1A1B07045995] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Insulin resistance, defined as attenuated sensitivity responding to insulin, impairs insulin action. Direct causes and molecular mechanisms of insulin resistance have thus far remained elusive. Here we show that alternative translation initiation (ATI) of Caveolin-2 (Cav-2) regulates insulin sensitivity. Cav-2 beta isoform yielded by ATI desensitizes insulin receptor (IR) via dephosphorylation by protein-tyrosine phosphatase 1B (PTP1B), and subsequent endocytosis and lysosomal degradation of IR, causing insulin resistance. Blockage of Cav-2 ATI protects against insulin resistance by preventing Cav-2 beta-PTP1B-directed IR desensitization, thereby normalizing insulin sensitivity and glucose uptake. Our findings show that Cav-2 beta is a negative regulator of IR signaling, and identify a mechanism causing insulin resistance through control of insulin sensitivity via Cav-2 ATI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available